Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q4 CY2024 results topping the market’s revenue ...

Inspire Medical Systems (NYSE:INSP – Get Free Report) had its price objective lowered by Truist Financial from $250.00 to $235.00 in a note issued to investors on Tuesday,Benzinga reports. The ...

Inspire Medical Systems (NYSE:INSP – Free Report) had its price target trimmed by Morgan Stanley from $230.00 to $220.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm ...

Q4 2024 Earnings Call Transcript February 10, 2025 Inspire Medical Systems, Inc. beats earnings expectations. Reported EPS is ...

Inspire Medical shares dipped — but have since mostly recovered — following news of a government investigation following Q4 ...

In a report released today, Jonathan Block from Stifel Nicolaus maintained a Hold rating on Inspire Medical Systems (INSP – Research Report), ...

John Rondoni, the Chief Technology Officer of Inspire Medical Systems, Inc. (NYSE:INSP), recently executed a stock sale as part of a pre-established trading plan. On February 11, Rondoni sold 583 ...

MINNEAPOLIS, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative ...

Tyler Technologies’ niche market limits growth potential. Find out why TYL stock is overpriced and at risk of a correction ...

Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024 MINNEAPOLIS, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc.